Abstract
The aim of this study was to determine whether the phosphatidylinositol 3-kinase (PI3K)-dependent mammalian target of rapamycin (mTOR)-eukaryotic initiation factor 4E binding protein 1 (4E-BP1) signal pathway and S6 kinase (S6K), the major element of the mTOR pathway, play a role in the enhanced vascular endothelial cell (EC) proliferation induced by cyclic strain. Bovine aortic ECs were subjected to an average of 10% strain at a rate of 60 cycles/min for < or =24 h. Cyclic strain-induced EC proliferation was reduced by pretreatment with rapamycin but not the MEK1 inhibitor PD-98059. The PI3K inhibitors wortmannin and LY-294002 also attenuated strain-induced EC proliferation and strain-induced activation of S6K. Rapamycin but not PD-98059 prevented strain-induced S6K activation, and PD-98059 but not rapamycin prevented strain-induced activation of extracellular signal-regulated kinases 1 and 2. Cyclic strain also activated 4E-BP1, which could be inhibited by PI3K inhibitors. These data suggest that the PI3K-dependent S6K-mTOR-4E-BP1 signal pathway may be critically involved in strain-induced bovine aortic EC proliferation.
Publication types
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
3-Phosphoinositide-Dependent Protein Kinases
-
Androstadienes / pharmacology
-
Animals
-
Antibiotics, Antineoplastic / pharmacology
-
Aorta / cytology
-
Carrier Proteins / metabolism*
-
Cattle
-
Cell Division / drug effects
-
Cell Division / physiology
-
Cells, Cultured
-
Chromones / pharmacology
-
Endothelium, Vascular / cytology*
-
Endothelium, Vascular / metabolism*
-
Enzyme Inhibitors / pharmacology
-
Flavonoids / pharmacology
-
Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
-
Mitogen-Activated Protein Kinase 1 / metabolism
-
Mitogen-Activated Protein Kinase 3 / antagonists & inhibitors
-
Mitogen-Activated Protein Kinase 3 / metabolism
-
Morpholines / pharmacology
-
Phosphatidylinositol 3-Kinases / metabolism*
-
Phosphodiesterase Inhibitors / pharmacology
-
Phosphoinositide-3 Kinase Inhibitors
-
Phosphoproteins / metabolism*
-
Phosphorylation
-
Protein Kinases / metabolism*
-
Protein Serine-Threonine Kinases / metabolism
-
Proto-Oncogene Proteins / metabolism
-
Proto-Oncogene Proteins c-akt
-
Ribosomal Protein S6 Kinases / metabolism
-
Signal Transduction / drug effects
-
Signal Transduction / physiology
-
Sirolimus / pharmacology
-
TOR Serine-Threonine Kinases
-
Wortmannin
Substances
-
3-Phosphoinositide-Dependent Protein Kinases
-
Androstadienes
-
Antibiotics, Antineoplastic
-
Carrier Proteins
-
Chromones
-
Enzyme Inhibitors
-
Flavonoids
-
Mitogen-Activated Protein Kinase 1
-
Mitogen-Activated Protein Kinase 3
-
Morpholines
-
Phosphatidylinositol 3-Kinases
-
Phosphodiesterase Inhibitors
-
Phosphoinositide-3 Kinase Inhibitors
-
Phosphoproteins
-
Protein Kinases
-
Protein Serine-Threonine Kinases
-
Proto-Oncogene Proteins
-
Proto-Oncogene Proteins c-akt
-
Ribosomal Protein S6 Kinases
-
Sirolimus
-
TOR Serine-Threonine Kinases
-
Wortmannin
-
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
-
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one